Universal Health Services Reports Strong Q4 Growth and Annual Profit Surge

Universal Health Services, Inc. (NYSE: UHS) has announced impressive financial results for the fourth quarter of 2025, with net income soaring to $445.9 million, or $7.06 per diluted share. This marks a significant increase from $332.4 million, or $4.96 per diluted share, reported in the same quarter of 2024. The company attributed this growth to a rise in net revenues, which increased by 9.1 percent to reach $4.486 billion compared to $4.114 billion a year earlier.

The report highlighted that the adjusted net income attributable to UHS was $371.4 million, or $5.88 per diluted share, up from $329.9 million, or $4.92 per diluted share in the fourth quarter of 2024. The results also included a $71.5 million after-tax unrealized gain linked to the company’s minority stake in a healthcare generative artificial intelligence firm, as well as an additional $0.8 million gain from the sale of certain equity securities.

Annual Performance and Future Outlook

For the full year, UHS reported a net income of $1.489 billion, or $23.10 per diluted share, which reflects a substantial increase from $1.142 billion, or $16.82 per diluted share, in 2024. The annual net revenues rose by 9.7 percent to $17.365 billion, compared to $15.828 billion the previous year. Adjusted net income for the year stood at $1.401 billion, or $21.74 per diluted share, up from $1.128 billion, or $16.61 per diluted share in 2024.

Earnings before interest, taxes, depreciation, and amortization (EBITDA) reached $2.725 billion for 2025, compared with $2.248 billion the previous year. Despite these gains, UHS reported that adjusted admissions at acute care hospitals remained unchanged in the fourth quarter year-over-year, while adjusted patient days saw a slight decline of 0.7 percent.

The behavioral health segment, however, showed positive momentum, with adjusted admissions increasing by 1.8 percent and adjusted patient days rising by 1.5 percent in the fourth quarter. For the full year, adjusted admissions at acute care hospitals increased by 1.6 percent, while adjusted patient days were up by 0.3 percent.

Financial Health and Share Buybacks

UHS reported a net cash flow from operating activities of $1.864 billion for 2025, compared to $2.067 billion in 2024. As of December 31, 2025, the company had $889 million in available borrowing capacity under its $1.3 billion revolving credit facility.

During the fourth quarter, UHS repurchased 1.461 million shares of its Class B common stock for approximately $333.5 million, averaging about $228 per share. Over the entire year, the company bought back 4.65 million shares at a total cost of approximately $899.3 million, averaging about $193 per share. As of December 31, 2025, UHS has approximately $1.425 billion remaining under its share repurchase authorization.

Looking ahead, UHS anticipates continued growth in revenue and earnings for 2026. The midpoint of the company’s revenue forecast indicates a 7.1 percent increase over the $17.365 billion reported for 2025. Projected adjusted EBITDA is expected to rise by 4.8 percent, while adjusted earnings per diluted share are projected to increase by 8.5 percent from the previous year.

The robust financial performance underscores UHS’s resilience and strategic positioning within the healthcare sector, further indicating its commitment to delivering quality services while enhancing shareholder value.